Aizhi Zhao

808 total citations
23 papers, 633 citations indexed

About

Aizhi Zhao is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Aizhi Zhao has authored 23 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Aizhi Zhao's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (4 papers). Aizhi Zhao is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (4 papers). Aizhi Zhao collaborates with scholars based in China, United States and Switzerland. Aizhi Zhao's co-authors include George Coukos, Nathalie Scholler, Mohammad Reza Tohidkia, Yadollah Omidi, Donald L. Siegel, Weihong Wen, Fa Yang, Weijun Qin, Donghui Han and Raphael Sandaltzopoulos and has published in prestigious journals such as PLoS ONE, Circulation Research and Cancer Research.

In The Last Decade

Aizhi Zhao

23 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aizhi Zhao China 13 297 196 196 166 103 23 633
Nandini Mondal United States 11 380 1.3× 166 0.8× 235 1.2× 50 0.3× 54 0.5× 13 657
Hyunbo Shim South Korea 17 439 1.5× 174 0.9× 173 0.9× 310 1.9× 30 0.3× 42 762
Nikko Brix Germany 8 155 0.5× 244 1.2× 132 0.7× 72 0.4× 109 1.1× 13 503
Christoph Rösli Switzerland 8 245 0.8× 137 0.7× 124 0.6× 168 1.0× 29 0.3× 10 487
Xiang-Min Yang China 15 680 2.3× 222 1.1× 336 1.7× 64 0.4× 47 0.5× 33 899
Oscar D. Bustuoabad Argentina 13 142 0.5× 223 1.1× 135 0.7× 42 0.3× 40 0.4× 34 475
Jun-Ting Cheng China 11 443 1.5× 345 1.8× 270 1.4× 82 0.5× 69 0.7× 15 852
Antonia Richter Germany 9 155 0.5× 209 1.1× 46 0.2× 202 1.2× 45 0.4× 15 443
David Sherris United States 16 459 1.5× 119 0.6× 102 0.5× 74 0.4× 80 0.8× 27 740

Countries citing papers authored by Aizhi Zhao

Since Specialization
Citations

This map shows the geographic impact of Aizhi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aizhi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aizhi Zhao more than expected).

Fields of papers citing papers by Aizhi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aizhi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aizhi Zhao. The network helps show where Aizhi Zhao may publish in the future.

Co-authorship network of co-authors of Aizhi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Aizhi Zhao. A scholar is included among the top collaborators of Aizhi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aizhi Zhao. Aizhi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Donghui, Chao Xu, Fa Yang, et al.. (2022). Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts. Molecular Medicine. 28(1). 37–37. 13 indexed citations
2.
Wu, Jieheng, Donghui Han, Shengjia Shi, et al.. (2019). A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer. Molecular Cancer Therapeutics. 18(7). 1289–1301. 10 indexed citations
3.
Jiao, Dian, Yu Li, Fa Yang, et al.. (2019). Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma. Clinical and Translational Gastroenterology. 10(5). e00041–e00041. 57 indexed citations
4.
Xu, Chen, et al.. (2019). Simple strategy for single-chain fragment antibody-conjugated probe construction. Life Sciences. 239. 117052–117052. 2 indexed citations
5.
Shi, Shengjia, Lijuan Wang, Donghui Han, et al.. (2019). Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer. Theranostics. 9(5). 1247–1263. 44 indexed citations
6.
Shao, Meng, Zhenqiang He, Zhixin Yin, et al.. (2018). Xihuang Pill Induces Apoptosis of Human Glioblastoma U‐87 MG Cells via Targeting ROS‐Mediated Akt/mTOR/FOXO1 Pathway. Evidence-based Complementary and Alternative Medicine. 2018(1). 6049498–6049498. 22 indexed citations
7.
Hu, Jia, Xiang Chen, Xuhua Zhang, et al.. (2018). A fusion‐protein approach enabling mammalian cell production of tumor targeting protein domains for therapeutic development. Protein Science. 27(5). 933–944. 3 indexed citations
8.
Zhou, Xiaobing, Li Liu, Chao Wang, et al.. (2016). Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene. Human Vaccines & Immunotherapeutics. 12(3). 732–739. 7 indexed citations
9.
Yuan, Xiaopeng, Xiang Chen, Xuhua Zhang, et al.. (2016). Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy. Cancer Immunology Immunotherapy. 66(3). 367–378. 12 indexed citations
10.
Yuan, Xiaopeng, Xiang Chen, Wei Yang, et al.. (2016). Efficient construct of a large and functional scFv yeast display library derived from the ascites B cells of ovarian cancer patients by three-fragment transformation-associated recombination. Applied Microbiology and Biotechnology. 100(9). 4051–4061. 6 indexed citations
11.
Li, Chunsheng, Junying Wang, Jia Hu, et al.. (2014). Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget. 5(16). 6994–7012. 13 indexed citations
12.
Zhao, Aizhi, Mohammad Reza Tohidkia, Donald L. Siegel, George Coukos, & Yadollah Omidi. (2014). Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Critical Reviews in Biotechnology. 36(2). 276–289. 81 indexed citations
13.
Laniti, Denarda Dangaj, Evripidis Lanitis, Aizhi Zhao, et al.. (2013). Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses. Cancer Research. 73(15). 4820–4829. 98 indexed citations
14.
Zhou, Xiaobing, Kai Gao, Aizhi Zhao, et al.. (2011). Modulation of immune and inflammatory responses on experimental arthritis following intraarticular gene transfer of tumor necrosis factor receptor-immunoglobulin Fc. Rheumatology International. 32(9). 2605–2614. 3 indexed citations
15.
Laniti, Denarda Dangaj, Karen L. Abbott, Ananda Mookerjee, et al.. (2011). Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody. PLoS ONE. 6(12). e28386–e28386. 37 indexed citations
16.
Zhu, Weizhong, Natalia Petrashevskaya, Shuxun Ren, et al.. (2011). G i -Biased β 2 AR Signaling Links GRK2 Upregulation to Heart Failure. Circulation Research. 110(2). 265–274. 63 indexed citations
17.
Zhao, Aizhi, Selene Nuñez-Cruz, Chunsheng Li, et al.. (2010). Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform. Journal of Immunological Methods. 363(2). 221–232. 41 indexed citations
18.
Lv, Yonggang, Ting Wang, Nanlin Li, et al.. (2010). T-Vector and In Vivo Recombination As Tools to Construct a Large Antibody Library of Breast Cancer. Hybridoma. 29(3). 251–254. 1 indexed citations
19.
Zhao, Aizhi, Weijun Qin, Weihong Wen, et al.. (2007). Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV. Microbes and Infection. 9(8). 1026–1033. 3 indexed citations
20.
Qin, Weijun, Aizhi Zhao, Weihong Wen, et al.. (2007). A Novel Technique for Efficient Construction of Large scFv Libraries. Molecular Biotechnology. 37(3). 201–205. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nandini Mondal Breakdown of academic impact, for papers by Hyunbo Shim Breakdown of academic impact, for papers by Nikko Brix Breakdown of academic impact, for papers by Christoph Rösli Breakdown of academic impact, for papers by Xiang-Min Yang Breakdown of academic impact, for papers by Oscar D. Bustuoabad Breakdown of academic impact, for papers by Jun-Ting Cheng Breakdown of academic impact, for papers by Antonia Richter Breakdown of academic impact, for papers by David Sherris
Rankless by CCL
2026